Clinical Trials on Pulmonary Atelectasis in Ireland

Total 300 results

Lifespan

Completed

Evaluating the Effectiveness of Incentive Spirometry

Pneumonia | Dyspnea | Atelectasis | Respiratory Rate | Oxygen Saturation | Oxygen Requirements | FEV1 | FVC | Re-intubation | Hospital Length of Stay | Nursing Workload | Incentive Spirometry

United States
Beaumont Hospital
Aerogen

Completed

A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Royal College of Surgeons, Ireland
University College Dublin; Connolly Hospital Blanchardstown

Completed

A 2 Week, Crossover Trial of Dietary Nitrate in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

Ireland
Beaumont Hospital
Royal College of Surgeons, Ireland

Completed

Preventing Repeat Hospitalisations in Patients With Chronic Obstructive Pulmonary Disease (COPD) (INCA R-ACE)

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Beaumont Hospital

Completed

Seasonal Trends in Pneumococcal Carriage in COPD Patients (Helios)

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Beaumont Hospital
GlaxoSmithKline; Health Research Board, Ireland; Asthma Society Ireland; Irish... and other collaborators

Completed

A Study of Inhaler Use in the Community

Chronic Obstructive Pulmonary Disease | Asthma | Airways Disease

Ireland
University of Dublin, Trinity College
Tallaght University Hospital

Completed

The Effect of a Smartphone Application Self-management Programme on Clinical Health Outcomes in Patients With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease

Ireland
Beaumont Hospital
Aerogen

Completed

Effectiveness of Vibrating Mesh Versus Small Volume Nebuliser in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation Acute

Ireland
MedImmune LLC

Completed

A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease Exacerbations

Chronic Obstructive Pulmonary Disease

Ireland
Beaumont Hospital
ITS Pulmonary Rehabilitation Research Network

Completed

Long-term Impact of Pulmonary Rehabilitation

Chronic Obstructive Pulmonary Disease

Ireland
Beaumont Hospital
University College Dublin

Completed

Acupuncture Combined With Pulmonary Rehabilitation: Are There Additional Benefits?

Chronic Obstructive Pulmonary Disease

Ireland
Beaumont Hospital

Completed

Long Term Evaluation of Activity Levels Post Pulmonary Rehabilitation

Chronic Obstructive Pulmonary Disease

Ireland
patientMpower Ltd.
Boehringer Ingelheim

Terminated

Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Ireland
patientMpower Ltd.
Health Service Executive, Ireland

Completed

Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Ireland
Elevre Medical Ltd.
Beacon Hospital

Completed

A Wearable In-phase Chest Wall Vibration Device for Relief of Dyspnoea in COPD: a First-in-human Exploratory Study (ResWave)

Chronic Obstructive Pulmonary Disease | Dyspnea

Ireland
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Germany, Ireland
Helga Jónsdóttir
University of Iceland

Completed

Partnership-based Nursing Practice for Lung Patients and Their Families

Chronic Obstructive Pulmonary Disease | Chronic Disease | Family

Iceland
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Beaumont Hospital
Royal College of Surgeons, Ireland

Completed

Teaching Inhaler Use With the INCA Device in a Community Pharmacy Setting

Pulmonary Disease, Chronic Obstructive | Asthma

Ireland
Lung Biotechnology PBC

Completed

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Ireland
Uptake Medical Corp

Completed

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (BTVA)

Chronic Obstructive Pulmonary Disease | Emphysema

Germany, Ireland, Australia, Austria
University College Dublin
Mater Misericordiae University Hospital

Recruiting

The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety Study (OPTICA)

Pregnancy Related | Venous Thromboembolism | Pulmonary Embolism

Ireland
Spanish Research Center for Respiratory Diseases

Unknown

Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease (REVASC)

Chronic Obstructive Pulmonary Disease

Spain
Synspira, Inc.

Terminated

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Lung Diseases | Cystic Fibrosis | Pulmonary Disease | Antibiotic Resistant Infection | Respiratory Tract Disease | Cystic Fibrosis Pulmonary Exacerbation | Lung Inflammation | Burkholderia Infections | Lung Infection | Multi-antibiotic Resistance | Pulmonary Inflammation | Lung Infection Pseudomonal | Cystic Fibrosis... and other conditions

United Kingdom
Rhode Island Hospital

Active, not recruiting

Effects of DHEA in Pulmonary Hypertension (EDIPHY)

Pulmonary Arterial Hypertension

United States
Beaumont Hospital

Recruiting

A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients

COVID-19 | Pneumonia | Respiratory Failure | Pulmonary Disease | COPD | Community-acquired Pneumonia

Ireland
Dey

Completed

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Lung Biotechnology PBC

Completed

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

Pulmonary Arterial Hypertension

United States, Ireland, Belgium
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United States
University of Pennsylvania

Completed

Anastrozole in Patients With Pulmonary Arterial Hypertension (AIPH)

Pulmonary Arterial Hypertension

United States
Edwards Lifesciences

Completed

Pulmonic Valve REplacement Multi-discIpline EMEA Registry (PREMIER)

Pulmonary Regurgitation | Pulmonary Insufficiency | Pulmonary Stenosis

Germany, Ireland, Belgium, Israel, United Kingdom, Italy, Poland, Saudi Arabia, Turkey
Eko Devices, Inc.

Recruiting

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

Pulmonary Hypertension

United States
National Jewish Health
University of Colorado, Denver; Vanderbilt University; Landspitali University...

Recruiting

Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) (GWAS)

Idiopathic Pulmonary Fibrosis | Idiopathic Interstitial Pneumonia | Familial Pulmonary Fibrosis | Familial Interstitial Pneumonia

United States, Iceland
VA Office of Research and Development

Completed

Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease (TADA-PHILD)

Pulmonary Hypertension | Chronic Obstructive Pulmonary Disease (COPD)

United States
VA Office of Research and Development
VA Eastern Colorado Health Care System; Atlanta VA Medical Center; VA Boston... and other collaborators

Recruiting

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH (BETTER COPD-PH)

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | Dyspnea

United States
Lung Biotechnology PBC

Completed

Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
Lung Biotechnology PBC

Completed

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

United States, Belgium, Czechia, Germany, Ireland, Romania
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Pulmonary Disease, Chronic Obstructive

United States
Sunovion

Completed

Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | Emphysema | Bronchitis

United States
Mount Sinai Hospital, Canada
Sunnybrook Health Sciences Centre; University of Iowa; The Rotunda Hospital; BC... and other collaborators

Completed

Novel Echocardiographic Methods for Early Identification of Neonates at Risk for Chronic Pulmonary Hypertension

Pulmonary Hypertension | Infant, Premature

Canada, United States, Ireland, United Kingdom
MedImmune LLC

Terminated

A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United States, Canada
Wen-Chih Wu

Withdrawn

Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

Steatosis | Right Ventricular Failure | Pulmonary; Hypertension

United States
Horizon Pharma USA, Inc.

Completed

A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

United States
Sunovion Respiratory Development Inc.

Completed

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

Chronic Obstructive Pulmonary Disease

United States, United Kingdom
St. James's Hospital, Ireland

Completed

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

Pneumonia | Adenocarcinoma | Respiratory Failure | Esophageal Cancer | Pulmonary Fibrosis | Surgery | Chemotherapy Effect | Radiation Toxicity | Squamous Cell Carcinoma | Radiation Pneumonitis | Radiation Fibrosis

Ireland
Trevi Therapeutics
Parexel

Completed

A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (CANAL)

Cough | Idiopathic Pulmonary Fibrosis | Nalbuphine

United Kingdom
Epix Pharmaceuticals, Inc.

Completed

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United States
University of Pennsylvania
Johns Hopkins University; University of Colorado, Denver; Washington University... and other collaborators

Completed

Pulmonary Hypertension and Anastrozole Trial (PHANTOM)

Pulmonary Arterial Hypertension

United States
Rhode Island Hospital
United Therapeutics

Terminated

Treprostinil Combined With Tadalafil for Pulmonary Hypertension (T2)

Pulmonary Arterial Hypertension

United States
GlaxoSmithKline

Completed

A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD). (ADC111114)

Pulmonary Disease, Chronic Obstructive

United States

Clinical Trials on Pulmonary Atelectasis in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations